Clinical Trials Directory

Trials / Completed

CompletedNCT00595842

Artificial Root-End Barriers

Clinical Success of Artificial Root-End Barriers With Mineral Trioxide Aggregate in Teeth With Immature Apices

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
The University of Texas Health Science Center at San Antonio · Academic / Other
Sex
All
Age
5 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study retrospectively looks to determine the clinical success of ProRoot MTA used as an artificial apical barrier in teeth with immature apices.

Detailed description

The normal development and maturation of a root depends on a vital, healthy pulp. If the pulp becomes necrotic in a tooth with an immature apex, endodontic treatment can be performed using an artificial barrier technique. Mineral trioxide aggregate (MTA) has become the material of choice to accomplish this procedure, however, few studies have evaluated its clinical success. The purpose of this retrospective study was to determine the clinical success of ProRoot MTA used as an artificial apical barrier. Twenty patients were included in this study. After approximately one week of Ca(OH)2 treatment, each patient had MTA placed as an apical barrier in a tooth with a single canal and open apex followed by placement of a final restoration. Patients were recalled and evaluated for clinical signs and symptoms and osseous healing. Immediate post-treatment and recall radiographs were evaluated by two endodontists calibrated for use of the Periapical Index (PAI).

Conditions

Timeline

Start date
2007-02-01
Primary completion
2008-06-01
Completion
2008-06-01
First posted
2008-01-16
Last updated
2012-03-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00595842. Inclusion in this directory is not an endorsement.